Details for New Drug Application (NDA): 205467
✉ Email this page to a colleague
The generic ingredient in FEBUXOSTAT is febuxostat. There are twenty-six drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the febuxostat profile page.
Summary for 205467
Tradename: | FEBUXOSTAT |
Applicant: | Sun Pharm |
Ingredient: | febuxostat |
Patents: | 0 |
Pharmacology for NDA: 205467
Mechanism of Action | Xanthine Oxidase Inhibitors |
Medical Subject Heading (MeSH) Categories for 205467
Suppliers and Packaging for NDA: 205467
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
FEBUXOSTAT | febuxostat | TABLET;ORAL | 205467 | ANDA | NorthStar RxLLC | 16714-059 | 16714-059-01 | 30 TABLET, FILM COATED in 1 BOTTLE (16714-059-01) |
FEBUXOSTAT | febuxostat | TABLET;ORAL | 205467 | ANDA | NorthStar RxLLC | 16714-060 | 16714-060-01 | 30 TABLET, FILM COATED in 1 BOTTLE (16714-060-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 40MG | ||||
Approval Date: | Jul 1, 2019 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 80MG | ||||
Approval Date: | Jul 1, 2019 | TE: | AB | RLD: | No |
Complete Access Available with Subscription